Nalaganje...
Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea
Clostridium difficile-associated diarrhea (CDAD) is the most common cause of healthcare-associated diarrhea. The current recommended treatment regimens of metronidazole and vancomycin have not changed in nearly 25 years. Fidaxomicin, an exceedingly narrow spectrum macrolide antibiotic, was recently...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3491684/ https://ncbi.nlm.nih.gov/pubmed/23152733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X12461294 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|